PA
NDAQ icon

PharVision Advisers’s Nasdaq NDAQ Stock Holding History

PharVision Advisers’s Portfolio NDAQ Stock Details NDAQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,836
Closed -$275K – 456
2025
Q4 		$275K Sell
2,836
-1,876
-40% -$169K 0.14% 328
2025
Q3 		$417K Buy
4,712
+2,406
+104% +$223K 0.23% 68
2025
Q2 		$206K Sell
2,306
-2,742
-54% -$219K 0.3% 200
2025
Q1 		$383K Buy
+5,048
New +$397K 0.53% 43

Other funds holding NDAQ

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PharVision Advisers's NDAQ Position: Q1 2026 in Review

PharVision Advisers sold out of Nasdaq (NDAQ) in Q1 2026, closing a stake of 2,836 shares — an estimated $275K sold.

PharVision Advisers first reported a position in NDAQ in Q1 2025 and held it in 4 quarters. The position peaked at $417K in Q3 2025. 1,086 funds tracked by Wall St. Rank hold NDAQ as of Q1 2026.

  • PharVision Advisers reported no remaining Nasdaq position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,836 Nasdaq shares in Q1 2026, an estimated $275K.
  • PharVision Advisers first reported a position in Nasdaq in Q1 2025 and held it in 4 quarters.
  • PharVision Advisers's Nasdaq position peaked at $417K in Q3 2025.
  • 1,086 funds tracked by Wall St. Rank held Nasdaq as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.